• ÆäÀ̽ººÏ °øÀ¯
  • Æ®À§ÅÍ °øÀ¯
  • ¹ÌÅõµ¥ÀÌ °øÀ¯
  • URLº¹»ç
  • ´õº¸±â
  • °ü½ÉÀÇ·áÁø µî·Ï

ÀÌ¿µÈ£

ÀÌ¿µÈ£

ÀÌ¿µÈ£ ±³¼öÀÇ Áø·á½Ã°£Ç¥ Áø·á¿¹¾à

Áø·á°ú/¼¾ÅÍ ¿ù È­ ¼ö ¸ñ ±Ý Åä Àü¹®Áø·á°ú¸ñ
·ù¸¶Æ¼½º³»°ú
¿ÀÀü
Á¾ÀÏ
¿ÀÀü
¿ÀÈÄ
- - °üÀý¿° , ·ù¸¶Æ¼½º , ·çǪ½º , Åëdz , °­Á÷¼ºÃ´Ãß¿° , ¼¶À¯±ÙÀ°Åë , °ñ´Ù°øÁõ

ÀÌ¿µÈ£ ±³¼öÀÇ »ó¼¼Á¤º¸

ÇзÂ

more
  •  ~  1991 .02  :  °í·Á´ëÇб³Àǰú´ëÇÐ Á¹¾÷ Çлç
  •  ~  1994 .02  :  °í·Á´ëÇб³´ëÇпø ¼®»ç
  •  ~  1996 .02  :  °í·Á´ëÇб³ Àǰú´ëÇпø ¹Ú»ç

°æ·Â

more
  • 1999  ~   :  ¹Ì±¹ÀÇ»ç¸éÇã (USMLE) Ãëµæ
  • 2003 .03  ~  2004 .02  :  UCLA ¿¬¼ö
  • 2004 .03  ~  2005 .02  :  OMRF ¿¬¼ö
  • 1999 .03  ~  2003 .02  :  °í·Á´ë ±¸·Îº´¿ø ·ù¸¶Æ¼½º³»°ú ºÐ°úÀå
  • 2012 .02  ~   :  °í·Á´ë ¾È¾Ïº´¿ø ·ù¸¶Æ¼½º³»°ú ºÐ°úÀå
  • 2011 .03  ~   :  °í·Á´ë ·ù¸¶Æ¼½º³»°ú ±³¼ö

¼ö»ó³»¿ª

more
  • 1999  :  ´ëÇѳ»°úÇÐȸ Çмú»ó
  • 2001  :  °í·Á´ëÀÇ·á¿ø Çмú»ó
  • 2010  :  °í·Á´ëÀÇ·á¿ø Çмú»ó
  • 2014  :  ´ëÇѳ»°úÇÐȸ Çмú»ó
  • 2014  :  È£ÀÇÀÇÇлó
  • 2019  :  ´ëÇÑ·ù¸¶Æ¼½ºÇÐȸ Çмú»ó

ÇÐȸȰµ¿

more
  • 1996 .03  ~   :  ´ëÇÑ·ù¸¶Æ¼½ºÇÐȸȸ¿ø
  • 1996 .03  ~   :  ´ëÇѳ»°úÇÐȸȸ¿ø
  • 2008 .08  ~  2010 .05  :  ´ëÇÑ·ù¸¶Æ¼½ºÇÐȸ À繫ÀÌ»ç
  • 2010 .05  ~  2012 .05  :  ´ëÇÑ·ù¸¶Æ¼½ºÇÐȸ ÀÌ»ç
  • 2016 .05  ~  2018 .05  :  ´ëÇÑ·ù¸¶Æ¼½ºÇÐȸ °¨»ç
  • 2018 .05  ~   :  ´ëÇÑ·ù¸¶Æ¼½ºÇÐȸ °£ÇàÀÌ»ç

±¹³»È°µ¿

more
  • 2005  ~  2007  :  ¼î±×·»ÁõÈıº ȯ¿ìȸ ÀÚ¹®ÀÇ»ç
  • 1999  ~  2007  :  ·çǪ½º¸¦ À̱â´Â »ç¶÷µé(ȯ¿ìȸ) ÀÚ¹®ÀÇ»ç

±¹¿ÜȰµ¿

more
  • 2009 .01  ~   :  Arthritis Research & Therapy, editorial board

³í¹®

more
  • [±¹¿Ü³í¹®] (Associations between functional FCGR2A R131H and FCGR3A F158V polymorphisms and responsiveness to TNF blockers in spondyloarthropathy, psoriasis and Crohn's disease: a meta-analysis)
  • [±¹¿Ü³í¹®] (Association between the CTLA-4 +49 A/G polymorphism and susceptibility to rheumatoid arthritis: a meta-analysis.)
  • [±¹¿Ü³í¹®] (The association between the mannose-binding lectin codon 54 polymorphism and systemic lupus erythematosus: a meta-analysis update.)
  • [±¹¿Ü³í¹®] (Associations between interleukin-23R polymorphisms and ankylosing spondylitis susceptibility: a meta-analysis.)
  • [±¹¿Ü³í¹®] (Associations between eNOS polymorphisms and susceptibility to systemic lupus erythematosus: a meta-analysis.)
  • [±¹¿Ü³í¹®] (The association between interleukin-6 polymorphisms and systemic lupus erythematosus: a meta-analysis.)
  • [±¹³»³í¹®] (Efficacy and safety of monthly 150 mg oral ibandronate in women with postmenopausal osteoporosis: a systematic review and meta-analysis of randomized controlled trials.)
  • [±¹¿Ü³í¹®] (The association between the PTPN22 C1858T polymorphism and systemic sclerosis: a meta-analysis.)
  • [±¹¿Ü³í¹®] (The association between the PTPN22 C1858T polymorphism and rheumatoid arthritis: a meta-analysis update.)
  • [±¹¿Ü³í¹®] (CTLA-4 and TNF-¥á promoter-308 A/G polymorphisms and ANCA-associated vasculitis susceptibility: a meta-analysis.)
  • [±¹¿Ü³í¹®] (Associations between interleukin-10 polymorphisms and susceptibility to rheumatoid arthritis: a meta-analysis.)
  • [±¹¿Ü³í¹®] (Efficacy and safety of tacrolimus therapy for lupus nephritis: a systematic review of clinical trials.)
  • [±¹¿Ü³í¹®] (Candidate gene studies of fibromyalgia: a systematic review and meta-analysis.)
  • [±¹¿Ü³í¹®] (The association between the PTPN22 C1858T polymorphism and systemic lupus erythematosus: a meta-analysis update.)
  • [±¹¿Ü³í¹®] (Associations between vitamin D receptor polymorphisms and susceptibility to rheumatoid arthritis and systemic lupus erythematosus: a meta-analysis.)
  • [±¹¿Ü³í¹®] (Tacrolimus for the treatment of active rheumatoid arthritis: a systematic review and meta-analysis of randomized controlled trials.)
  • [±¹¿Ü³í¹®] (The efficacy and safety of rituximab for the treatment of active rheumatoid arthritis: a systematic review and meta-analysis of randomized controlled trials.)
  • [±¹¿Ü³í¹®] (Associations between tumor necrosis factor-alpha (TNF-alpha) -308 and -238 G/A polymorphisms and shared epitope status and responsiveness to TNF-alpha blockers in rheumatoid arthritis: a metaanalysis update.)
  • [±¹¿Ü³í¹®] (Induction and maintenance therapy for lupus nephritis: a systematic review and meta-analysis.)
  • [±¹¿Ü³í¹®] (Associations between the C677T and A1298C polymorphisms of MTHFR and the efficacy and toxicity of methotrexate in rheumatoid arthritis: a meta-analysis.)
  • [±¹¿Ü³í¹®] (Lack of association of TNF-alpha promoter polymorphisms with ankylosing spondylitis: a meta-analysis.)
  • [±¹¿Ü³í¹®] (The PTPN22 C1858T functional polymorphism and autoimmune disease- a meta-analys)
  • [±¹¿Ü³í¹®] (Tumor necrosis factor-alfa promoter -308 A/G polymorphism and rheumatoid arthritis susceptibility: a metaanalysis)

Àú¼­

more
  • Harrison's ³»°úÇÐ

ÃÖÁ¾¼öÁ¤ÀÏ : 2019.03.22